* AMN Healthcare Services Inc AMN.N AMN is expected
to show a
fall in quarterly revenue when it reports results on November
2.
* The Dallas Texas-based company is expected to report a
25.2% decrease in revenue to $851.196 million from $1.14 billion
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data. The company's guidance on August 3 2023, for
the period ended September 30, was for revenue between 840.00
million and 860.00 million.
* Refinitiv's mean analyst estimate for AMN Healthcare
Services
Inc is for earnings of $1.64 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for AMN
Healthcare
Services Inc is $103, above its last closing price of $75.86.
The company's guidance on August 3 2023 for the period ended
September 30 was for Earnings before Interest and Taxes between
73.92 million and 80.84 million.The company's guidance on August
3 2023 for the period ended September 30 was for Earnings before
Interest, Taxes, Depreciation and Amortization of between 840
million and 127.28 million.The company's guidance on August 3
2023 for the period ended September 30 was for gross profit
margin between 33.3% and 33.8%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 2.15 2.14 2.38 Beat 11
Mar. 31 2023 2.35 2.36 2.49 Beat 5.6
Dec. 31 2022 2.19 2.14 2.48 Beat 15.9
Sep. 30 2022 2.39 2.37 2.57 Beat 8.5
Jun. 2.99 2.97 3.31 Beat 11.6
30 2022
Mar. 31 2022 3.22 3.20 3.49 Beat 9
Dec. 31 2021 2.77 2.66 2.95 Beat 11.1
Sep. 30 2021 1.31 1.30 1.73 Beat 32.7
This summary was machine generated November 1 at 02:41 GMT. All
figures in US dollars unless otherwise stated